Solian: Advanced Atypical Antipsychotic for Schizophrenia Management
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.26 | $97.73 (0%) | 🛒 Add to cart |
| 60 | $2.99 | $195.46 $179.34 (8%) | 🛒 Add to cart |
| 90 | $2.90 | $293.19 $260.95 (11%) | 🛒 Add to cart |
| 120 | $2.86 | $390.93 $343.57 (12%) | 🛒 Add to cart |
| 180 | $2.81 | $586.39 $505.79 (14%) | 🛒 Add to cart |
| 270 | $2.78
Best per pill | $879.58 $750.62 (15%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.99 | $89.67 (0%) | 🛒 Add to cart |
| 60 | $2.74 | $179.34 $164.23 (8%) | 🛒 Add to cart |
| 90 | $2.65 | $269.01 $238.79 (11%) | 🛒 Add to cart |
| 120 | $2.61 | $358.69 $313.35 (13%) | 🛒 Add to cart |
| 180 | $2.56 | $538.03 $461.45 (14%) | 🛒 Add to cart |
| 270 | $2.54
Best per pill | $807.04 $686.14 (15%) | 🛒 Add to cart |
Synonyms | |||
Solian (amisulpride) is a modern atypical antipsychotic medication designed for the effective management of schizophrenia and related psychotic disorders. It functions by modulating dopamine activity in the brain, specifically targeting D2 and D3 receptors, which helps restore neurotransmitter balance with a favorable side effect profile compared to first-generation antipsychotics. Clinically proven to reduce both positive and negative symptoms of schizophrenia, Solian supports long-term remission and improved functional outcomes for patients. Its selective receptor affinity minimizes extrapyramidal symptoms, making it a well-tolerated option for sustained therapeutic use.
Features
- Contains amisulpride as the active ingredient
- Available in 50 mg, 100 mg, 200 mg, and 400 mg film-coated tablets
- Selective dopamine D2 and D3 receptor antagonist
- High bioavailability (~48%) with linear pharmacokinetics
- Administered orally, with or without food
- Manufactured under strict pharmaceutical quality standards
Benefits
- Effectively reduces positive symptoms such as hallucinations and delusions
- Improves negative symptoms including social withdrawal and apathy
- Lower incidence of extrapyramidal side effects compared to typical antipsychotics
- Supports enhanced patient adherence due to once or twice-daily dosing flexibility
- Contributes to long-term stability and relapse prevention
- Promotes better overall quality of life and social functioning
Common use
Solian is primarily indicated for the treatment of schizophrenia in adults. It is effective across the spectrum of psychotic symptoms and is often prescribed both in acute episodes and for maintenance therapy. In some regions, it may also be used off-label for dysthymia or other psychiatric conditions under specialist supervision.
Dosage and direction
The dosage of Solian must be individualized based on symptom profile, patient response, and tolerability. For positive symptoms, the usual dose ranges from 400 mg to 800 mg per day, administered in two divided doses. For predominant negative symptoms, lower doses (50–300 mg daily) may be sufficient. Dosage adjustments should be made gradually, and treatment should be initiated under medical supervision. Tablets should be swallowed whole with water and can be taken with or without food.
Precautions
Patients should be monitored regularly for clinical response and potential adverse effects. Caution is advised in patients with cardiovascular disease, Parkinson’s disease, or renal impairment. Solian may cause sedation; patients should avoid driving or operating machinery until their response is known. Regular assessments of metabolic parameters, including weight, blood glucose, and lipid levels, are recommended during treatment.
Contraindications
Solian is contraindicated in patients with known hypersensitivity to amisulpride or any excipients in the formulation. It should not be used in patients with phaeochromocytoma, prolactin-dependent tumours, or in combination with levodopa. Concomitant use with other CNS depressants or QT-prolonging agents should be avoided unless strictly necessary.
Possible side effects
Common side effects may include hyperprolactinaemia, weight gain, insomnia, anxiety, and gastrointestinal disturbances. Less frequently, extrapyramidal symptoms, hypotension, or QT prolongation may occur. Rare but serious adverse effects include neuroleptic malignant syndrome and tardive dyskinesia. Any unusual symptoms should be reported to a healthcare provider promptly.
Drug interaction
Solian may interact with other dopamine antagonists, antihypertensives, and medications that prolong the QT interval. Concomitant use with alcohol or other CNS depressants may enhance sedative effects. Caution is advised when administering with drugs that inhibit CYP450 enzymes, although amisulpride is not extensively metabolized by this system.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling the dose is not recommended.
Overdose
Symptoms of overdose may include severe sedation, hypotension, extrapyramidal symptoms, and QT prolongation. Management is supportive and symptomatic; gastric lavage may be considered if ingestion was recent. There is no specific antidote; ECG monitoring and specialist care are essential in suspected overdose cases.
Storage
Store below 30°C in a dry place, protected from light. Keep out of reach of children. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis, treatment decisions, and personalized dosage recommendations. Use only as prescribed.
Reviews
Clinical studies and patient reports indicate that Solian is effective in managing schizophrenia symptoms with a generally acceptable tolerability profile. Many patients experience significant improvement in both positive and negative symptoms, though individual responses may vary. Hyperprolactinaemia and weight gain are noted in some cases, but overall satisfaction remains high among users under appropriate medical supervision.